Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Kono Responsible for Logistics Part of COVID-19 Vaccine Rollout
January 19, 2021
-
REGULATORY Kono Tapped to Oversee COVID-19 Vaccine Rollout
January 19, 2021
-
BUSINESS BIKEN to Stop Shipment of Japanese Encephalitis Vaccine on Bacterial Contamination
January 18, 2021
-
REGULATORY Special Mitigation Margin for COVID-19 Up for Debate towards FY2022 Drug Price Revision: MHLW Bureau Chief
January 15, 2021
-
BUSINESS Nichi-Iko Announces Yet Another Recall, 38 Products Added to Bring Total to 75
January 14, 2021
-
ORGANIZATION Generic Use Targets Should Be Set by City/Ward in Major Prefectures: Professor
January 14, 2021
-
REGULATORY MHLW to Run Fresh Survey on Drug Makers’ Responses to Promotion Guidelines
January 13, 2021
-
BUSINESS Kobayashi Kako Expected to Face Administrative Penalty This Fiscal Year, Biz Suspension Likely
January 12, 2021
-
BUSINESS Drug Makers, Wholesalers Boost WFH as Japan Declares Second Emergency
January 12, 2021
-
COMMENTARY Potential Reimbursement Challenges of Aducanumab Could Usher in Health Insurance Overhaul in Japan
January 8, 2021
-
REGULATORY PMDA Updates Veklury Label to Allow Its Use in Moderate COVID-19
January 8, 2021
-
ORGANIZATION Japan Pharma Lobbies Shifting to Manabe/Okada Leadership? Their Abilities Will Be Tested as Industry Grapples with Thorny Issues
January 7, 2021
-
ACADEMIA Japan Reports Mother-to-Infant Cervical Tumor Transmission via Amniotic Fluids
January 7, 2021
-
BUSINESS Drug Makers, Wholesalers Brace for Second Emergency Declaration in Japan
January 6, 2021
-
ORGANIZATION 5% Discrepancy Line a Bad Surprise, FPMAJ Exec Says Drug Prices Will Now Go Down at Double Speed with Annual Re-Pricing
January 5, 2021
-
REGULATORY Govt Eager to Roll Out 1st COVID-19 Vaccine by Late February; PM Says Pfizer’s Japan Data Ready by Month-End
January 5, 2021
-
COMMENTARY Japan Rushing to Build COVID-19 Vaccination Regime as 1st Approval Draws Near
December 28, 2020
-
TRENDS Top 10 PHARMA JAPAN Articles in 2020
December 28, 2020
-
BUSINESS AstraZeneca to Accelerate Growth of Forxiga with Heart Failure Use, Gets Head Start in Arena before Rival Jardiance
December 28, 2020
-
REGULATORY MHLW Approves Label Expansions for Olumiant, Gardasil, Lynparza and More
December 28, 2020
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…